Venture-backed AbCellera closes Nasdaq IPO, raises $555m
AbCellera, a Vancouver, British Columbia-based developer of therapeutic antibodies, has closed its IPO on the NASDAQ at a price of US$20 per share, including the greenshoe option.
AbCellera, a Vancouver, British Columbia-based developer of therapeutic antibodies, has closed its IPO on the NASDAQ at a price of US$20 per share, including the greenshoe option.
Copyright PEI Media
Not for publication, email or dissemination